Fate Therapeutics (FATE) Jumps: Stock Moves 12.4% Higher – Tale of the Tape
Fate Therapeutics, Inc. (FATE) was a big mover last session with its shares rising over 12% on the day. This led to far more shares changing hands yesterday than in a normal session. The move continues the recent uptrend of the company as the stock has gained roughly 36% in the past one-month time frame.
This clinical-stage biopharmaceutical company has seen no estimate revision in the last 30 days. The Zacks Consensus Estimate hasn’t been in trend either. Yesterday’s rally is encouraging though, so make sure to keep a close watch on this firm in the near future.
Subscribe Now & Begin Receiving Biotech Stocks News, Articles, Trade Alerts & MORE, all 100% FREE!
We are your #1 source for all things Biotech Stocks, Subscribe Below!